| Amount | Holding |
|---|---|
| 1.48% | bioMerieux SA |
| 1.33% | GlaxoSmithKline plc |
| 1.33% | Ipsen SA |
| 1.25% | Roche Holding AG |
| 1.22% | Deutsche Telekom AG |
| 1.17% | Sartorius Stedim Biotech SA |
| 1.11% | Coloplast A/S Class B |
| 1.10% | Aviva plc |
| 1.07% | Deutsche Wohnen SE |
| 1.07% | Novartis AG |
Diversification Rating
2 /10
Expense Ratio Rating
8 /10
Expense Rating
6 /10
Market Score
1 /10
Category Score
10 /10
Market Size
1 /10
WisdomTree International Multifactor Fund
Expenses: 0.38% (Better than 1% of similar funds)
This is a bad choice for a Large Blend International Stocks fund. See why ยป
| Amount | Holding |
|---|---|
| 1.48% | bioMerieux SA |
| 1.33% | GlaxoSmithKline plc |
| 1.33% | Ipsen SA |
| 1.25% | Roche Holding AG |
| 1.22% | Deutsche Telekom AG |
| 1.17% | Sartorius Stedim Biotech SA |
| 1.11% | Coloplast A/S Class B |
| 1.10% | Aviva plc |
| 1.07% | Deutsche Wohnen SE |
| 1.07% | Novartis AG |
Minafi - The intersection of FI, minimalism & mindfulness.
Don't miss out on new posts, courses, interactive articles and more!
Join & Get Your First Course Free© 2025 Adam Fortuna
Site Map